How Life Sciences Cos. Can Prepare For Legal And PR Crises
By Mark Goodman, Maura Kathleen Monaghan, Paul Rubin, Jacob Stahl (December 13, 2018, 12:24 PM EST) -- Life sciences companies are susceptible to a wide range of legal crises that could expose them to legal liability, negatively impact commercial relationships and destroy reputations built over many years. A crisis can trigger concurrent investigations by Congress, the U.S. Food and Drug Administration, the U.S. Securities and Exchange Commission (for publicly traded companies), the U.S. Department of Justice and, potentially, other federal and state regulatory agencies. In addition, life sciences companies may be named in lawsuits alleging violations of the False Claims Act, product liability lawsuits and class actions in multiple jurisdictions, while also being subject to extensive media scrutiny....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!